Selected article for: "acute sars cov respiratory syndrome coronavirus and adipose tissue"
Author: Engin, Ayse Basak; Engin, Evren Doruk; Engin, Atilla
Title: Two important controversial risk factors in SARS-CoV-2 infection: Obesity and smoking
  • Cord-id: 60rzbotx
  • Document date: 2020_5_15
    • ID: 60rzbotx
    Snippet: The effects of obesity and smoking in the coronavirus disease 2019 (COVID-19) pandemic remain controversial. Angiotensin converting enzyme 2 (ACE2), a component of the renin-angiotensin system (RAS), is the human cell receptor of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19. ACE2 expression increases on lung alveolar epithelial cells and adipose tissue due to obesity, smoking and air pollution. A significant relationship exists between air polluti
    Document: The effects of obesity and smoking in the coronavirus disease 2019 (COVID-19) pandemic remain controversial. Angiotensin converting enzyme 2 (ACE2), a component of the renin-angiotensin system (RAS), is the human cell receptor of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19. ACE2 expression increases on lung alveolar epithelial cells and adipose tissue due to obesity, smoking and air pollution. A significant relationship exists between air pollution and SARS-CoV-2 infection, as more severe COVID-19 symptoms occur in smokers; comorbid conditions due to obesity or excess ectopic fat accumulation as underlying risk factors for severe COVID-19 strongly encourage the virus/ACE2 receptor-ligand interaction concept. Indeed, obesity, air pollution and smoking associated risk factors share underlying pathophysiologies that are related to the Renin-Angiotensin-System in SARS-CoV-2 infection. The aim of this review is to emphasize the mechanism of receptor-ligand interaction and its impact on the enhanced risk of death due to SARS-CoV-2 infection.

    Search related documents:
    Co phrase search for related documents
    • ace activity and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8
    • ace activity and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
    • ace activity increase and activity level: 1, 2
    • ace activity increase and acute ards respiratory distress syndrome: 1
    • ace activity increase and acute respiratory syndrome: 1, 2, 3, 4, 5
    • ace expression and active smoking: 1
    • ace expression and activity level: 1, 2, 3
    • ace expression and acute ards respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8
    • ace expression and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • ace expression and adaptive immune response: 1
    • ace expression increase and acute respiratory syndrome: 1, 2, 3, 4, 5, 6
    • activation endocytosis and acute respiratory syndrome: 1, 2, 3
    • active smoking and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • activity level and acute ards respiratory distress syndrome: 1
    • activity level and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • activity level and adaptive immune response: 1
    • acute ards respiratory distress syndrome and adaptive immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11